The O 6 -methylguanine-DNA methyltransferase (MGMT) promoter methylation status and clinical outcomes of Ewing sarcoma patients treated with irinotecan and temozolomide.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology(2022)

引用 0|浏览5
暂无评分
摘要
-promoter methylation did not correlate with clinical activity or outcomes following the IT regimen for advanced ES. However, methylated predicted significantly superior PFS following initiation of the standard VDC-IE protocol.
更多
查看译文
关键词
Ewing sarcoma,MGMT methylation,biomarkers,prognosis,survival
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要